Trilaciclib - G1 Therapeutics
At a glance
- Drug Originator G1 Therapeutics
- Drug Licenced by Boehringer Ingelheim; Simcere Pharmaceutical Group
- Drug Class Amines; Antineoplastics; Aza compounds; Chemoprotectants; Cyclohexanes; Ketones; Piperazines; Pyrazines; Pyridines; Pyrimidines; Pyrroles; Radioprotectives; Small molecules; Spiro compounds
- Mechanism of Action Cyclin-dependent kinase 4 inhibitors; Cyclin-dependent kinase 6 inhibitors
- USA Patent Applicants PHARMACOSMOS
- USA Patents 32
- NDAs 1
- International Patents 143
Disclaimer